ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Therefore, the RNA/DNA ratio can be used as an estimator of the transcript expression per CML cell and may provide additional information about the dynamics of BCR::ABL1 transcriptional activity under ongoing TKI therapy.